Board of Directors

Martin Nicklasson

Chairman of the Board
Chairman of the Remuneraation Committee and of the Nomination Committee; member of the Audit Committee.

Elected to the Board in 2015 and regarded as an independent board member.

Special competencies
Extensive general management and research and development experience from AstraZeneca Plc and Swedish Orphan Biovitrum AB.

Current positions
Board member of Basilea Pharmaceutica Ltd. and chairman of Nykode Therapeutics AS.

Kirsten A. Drejer

Vice Chairman of the Board
Elected to the Board in 2018 and regarded as an independent board member.
Chairman of the Scientific Committee.

Special competencies
More than 30 years of international experience in the pharmaceutical and biotech industry. Before co-founding Symphogen A/S in 2000, held several scientific and managerial positions at Novo Nordisk A/S.

Current positions
Chairman of the board of Antag Therapeutics, Bioneer and ResoTher Pharma. Board member of Curasight A/S and Malin Corporation.

Jeffrey Berkowitz

Board member
Member of the Audit Committee.

Elected to the Board in 2019 and regarded as an independent board member.

Special competencies
Global executive with extensive branded and generic pharmaceutical, retail pharmacy, wholesale drug distribution, specialty, payor and healthcare services leadership experience in P&L accountable roles.

Current positions
He is a board member of H. Lundbeck A/S, Esperion Theraptics, Inc. and Uniphar PLC.

Bernadette Connaughton

Board member
Member of the Audit Committee.

Elected to the Board in 2019 and regarded as an independent board member.

Special competencies
More than 30 years of global strategic, commercial and leadership expertise, and a broad perspective on the strategy, capabilities and governance required for successful execution in U.S. and international markets.

Current Positions
She is a board member of the board of Halozyme Therapeutics Inc. and Syneos Health.

Leonard Kruimer

Board member
Chairman of the Audit Committee.

Elected to the Board in 2019 and regarded as an independent board member.

Special competencies
More than 30 years of experience in corporate finance, planning and strategy, including 15 years in senior executive positions in private and publicly listed biotechnology companies.

Current positions
Chairman of the board of BioInvent Int. AB., board member of Oncoytics Biotech Inc. and board member and Chairman of Audit Committee of Pharming Group NV. Director AI Global (Netherlands) PCC Ltd.

Alain Munoz

Board member
Member of the Remuneration and Scientific Committee.

Elected to the Board in 2005 (resigned in 2006, was re-elected in 2007).

Special competencies
Physician qualified cardiology and intensive care. Experience in the pharmaceutical industry at senior management level. Served as SVP for international development in the Sanofi Group and in the pharmaceutical division of Fournier Laboratories.

Current positions
He is on the Scientific Advisory Board of Valneva SE, chairman of the board of directors of Acticor Biotech, and a board member of Auris Medical and Amryt Pharma Plc.

Michael J. Owen

Board member
Member of the Remuneration and Scientific Committee.

Elected to the Board in 2012 and regarded as an independent board member.

Special competencies
Research experience focusing on the immune system and more than 150 publications. Has held several leading positions at GlaxoSmithKline, most recently as SVP and head of biopharmaceuticals research.

Current positions
Chairman of the board of Ossianix Inc., and is a member of the board of ReNeuron Group plc, Sareum Holdings plc, and GammaDelta Therapeutics.

Anneline Nansen

Employee-elected board member
Instated as first alternate to the Board in 2021.

Current positions
Principal Scientist.

Frederik Barfoed Beck

Employee-elected board member
Elected to the Board in 2020.

Current positions
Senior Outsourcing Manager.

Louise Gjelstrup

Employee-elected board member
Elected to the Board in 2020.

Current positions
Laboratory Technician and Project Assistant.

Jens Peter Stenvang

Employee-elected board member
Elected to the Board in 2014.

Current positions
Senior Application Specialist.

Enrique Conterno

Board observer
Served at Eli Lilly and Company as SVP and a member of the executive committee; president of Lilly USA from January 2017 and president of Lilly Diabetes from 2009 until retirement from Eli Lilly and Company in 2019. 

Current positions
Member of the board of Glooko, Inc.; member of the board of governors of the American Red Cross.

Elaine Sullivan

Board observer
Served at AstraZeneca and Eli Lilly and Company as a member of the senior global R&D management teams.  

Current positionsMember of the board of Nykode Therapeutics ASA, IP Group plc, and hVIVO Ltd; member of the supervisory board of Evotec AG.